Article Text

Download PDFPDF
Amyotrophic lateral sclerosis and frontotemporal dementia
  1. Matthew C Kiernan
  1. Neuroscience Research Australia and University of New South Wales, Sydney, New South Wales, Australia
  1. Correspondence to Professor Matthew C Kiernan, Neuroscience Research Australia, Barker Street, Randwick, Sydney, NSW 2031, Australia; m.kiernan{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In the first of JNNP's mini-themed issues, we investigate how clinical research is making in-roads in the search for the common and overlapping threads that bind amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). These emerging threads may ultimately provide the cipher to unlock the pathophysiology of both diseases, and in turn produce effective treatments from across multiple disciplines.

In the realm of neurosciences, clinical overlap has become no more apparent over recent years than ALS and FTD. Although ALS was previously regarded as a motor disorder that spared cognitive abilities, it is now clear that a significant proportion of ALS patients develop cognitive dysfunction, and in a minority, overt dementia.1 In addition to motor-onset ALS presentations, a further subgroup of patients may initially present with FTD but later develop features of ALS. While a …

View Full Text


  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles